Oral Vaccine Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET INTRODUCTION
Vaccination is the efficient and cost effective way to prevent various infectious disorders. The vaccination has prevented the transmission of lethal diseases such as polio, measles across the globe. Oral vaccination has taken immunization process to the next level. Majority of vaccines are given by parenteral route because of instability in gastric environment but for some vaccines the oral route is cost effective and feasible to combat non- mucosal transmitted infections. Oral vaccination has positive patient compliance than parenteral vaccines.
MARKET DYNAMICS
The oral vaccine market is anticipated to grow in the forecast period owing to rising prevalence of infectious disorders and diseases along with efficient and safe nature of oral vaccines. Moreover, resistance issues with existing vaccines and various government initiatives to promote vaccination is also expected to boost market growth. Whereas, first pass metabolism issues with some drugs is the major restraining factor for the market growth.
MARKET SCOPE
The "Oral Vaccine Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Oral Vaccine market with detailed market segmentation by vaccine type, application and end user. The Oral Vaccine Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Oral Vaccine Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Oral Vaccine Market is segmented on the basis of vaccine type, application and end user. On the basis of vaccine type the market is segmented as, live vaccine, inactive vaccine, recombinant vaccine and others. On the basis of application the market is bifurcated as, polio, rabies, TB, influenza, respiratory infections, HIV, others. And on the basis of end user the market is segmented as, hospitals, government vaccination program, research program, others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Oral Vaccine Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Oral Vaccine Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Oral Vaccine Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Oral Vaccine Market in these regions.
By Vaccine Type
By Application
By End User
MARKET PLAYERS
The report covers key developments in the Oral Vaccine Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Oral Vaccine Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Oral Vaccine market in the global market. Below mentioned is the list of few companies engaged in the Oral Vaccine Market.
The report also includes the profiles of key players in Oral Vaccine Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Vaccination is the efficient and cost effective way to prevent various infectious disorders. The vaccination has prevented the transmission of lethal diseases such as polio, measles across the globe. Oral vaccination has taken immunization process to the next level. Majority of vaccines are given by parenteral route because of instability in gastric environment but for some vaccines the oral route is cost effective and feasible to combat non- mucosal transmitted infections. Oral vaccination has positive patient compliance than parenteral vaccines.
MARKET DYNAMICS
The oral vaccine market is anticipated to grow in the forecast period owing to rising prevalence of infectious disorders and diseases along with efficient and safe nature of oral vaccines. Moreover, resistance issues with existing vaccines and various government initiatives to promote vaccination is also expected to boost market growth. Whereas, first pass metabolism issues with some drugs is the major restraining factor for the market growth.
MARKET SCOPE
The "Oral Vaccine Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Oral Vaccine market with detailed market segmentation by vaccine type, application and end user. The Oral Vaccine Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Oral Vaccine Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Oral Vaccine Market is segmented on the basis of vaccine type, application and end user. On the basis of vaccine type the market is segmented as, live vaccine, inactive vaccine, recombinant vaccine and others. On the basis of application the market is bifurcated as, polio, rabies, TB, influenza, respiratory infections, HIV, others. And on the basis of end user the market is segmented as, hospitals, government vaccination program, research program, others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Oral Vaccine Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Oral Vaccine Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Oral Vaccine Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Oral Vaccine Market in these regions.
Oral Vaccine Market Report Analysis
Oral Vaccine Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Serum Institute of India Pvt Ltd
- GlaxoSmithKline Plc
- Merck and Co Inc
- Aventis
- PaxVax Corporation
- VALNEVA Canada Inc
- Janssen Pharmaceuticals
- Shanghai BravoBio Co Ltd
- Swiss Serum and Vaccine Institute Berne
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Vaccine Type
- Live vaccine
- Inactive Vaccine
- Recombinant Vaccine
- Others
By Application
- Polio
- Rabies
- Tuberculosis
- Influenza
- Respiratory infections
- HIV
- Others
By End User
- Hospitals
- Government vaccination programs
- Research institutes
- Others
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report covers key developments in the Oral Vaccine Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Oral Vaccine Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Oral Vaccine market in the global market. Below mentioned is the list of few companies engaged in the Oral Vaccine Market.
The report also includes the profiles of key players in Oral Vaccine Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Serum Institute of India Pvt. Ltd.
- GlaxoSmithKline plc.
- Merck and Co. Inc.
- Aventis
- PaxVax Corporation
- VALNEVA Canada, Inc.
- Janssen Pharmaceuticals
- Shanghai BravoBio Co., Ltd.
- Swiss Serum and Vaccine Institute Berne
- QUIMICA SUIZA S.A
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Oral Vaccine Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Vaccine Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1.Serum Institute of India Pvt. Ltd
2.GlaxoSmithKline Plc
3.Merck and Co. Inc
4.Aventis
5.PaxVax Corporation
6.VALNEVA Canada Inc
7.Janssen Pharmaceuticals
8.Shanghai BravoBio Co., Ltd
9.Swiss Serum and Vaccine Institute Berne
10.QUÍMICA SUIZA S.A
1.Serum Institute of India Pvt. Ltd
2.GlaxoSmithKline Plc
3.Merck and Co. Inc
4.Aventis
5.PaxVax Corporation
6.VALNEVA Canada Inc
7.Janssen Pharmaceuticals
8.Shanghai BravoBio Co., Ltd
9.Swiss Serum and Vaccine Institute Berne
10.QUÍMICA SUIZA S.A
Get Free Sample For